KMID : 1137020220330040050
|
|
Journal of Gynecologic Oncology 2022 Volume.33 No. 4 p.50 ~ p.50
|
|
TP53 variants in p53 signatures and the clonality of STICs in RRSO samples
|
|
Akahane Tomoko
Masuda Kenta Hirasawa Akira Kobayashi Yusuke Ueki Arisa Kawaida Miho Misu Kumiko Nakamura Kohei Nagai Shimpei Chiyoda Tatsuyuki
|
|
Abstract
|
|
|
Objective: Precursor lesions may be identified in fallopian tube tissue after risk-reducing salpingo-oophorectomy (RRSO) in patients with pathogenic variants of BRCA1/2. Serous tubal intraepithelial carcinoma (STIC) is considered a precursor of high-grade serous carcinoma, whereas the significance of the p53 signature remains unclear. In this study, we investigated the relationship between the p53 signature and the risk of ovarian cancer.
Methods: We analyzed the clinicopathological findings and conducted DNA sequencing for TP53 variants of p53 signatures and STIC lesions isolated using laser capture microdissection in 13 patients with pathogenic variants of BRCA1/2 who underwent RRSO and 17 control patients with the benign gynecologic disease.
Results: TP53 pathogenic variants were detected significantly higher in RRSO group than control (p<0.001). No difference in the frequency of p53 signatures were observed between groups (53.8% vs 29.4%; p=0.17). TP53 sequencing and next-generation sequencing analysis in a patient with STIC and occult cancer revealed 2 TP53 mutations causing different p53 staining for STICs and another TP53 mutation shared between STIC and occult cancer.
Conclusion: The sequence analysis for TP53 revealed 2 types of p53 signatures, one with a risk of progression to STIC and ovarian cancer with pathological variants in TP53 and the other with a low risk of progression without pathological variants in TP53 as seen in control.
|
|
KEYWORD
|
|
Prophylactic Surgical Procedures, Salpingo-Oophorectomy, Genes, p53, Genes, BRCA1, Genes, BRCA2, Carcinoma in Situ, Cystadenocarcinoma, Serous
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|